This Is MS Multiple Sclerosis Knowledge & Support Community

Posted: **Tue May 18, 2010 5:22 am**

Apitope, the European biotech company developing therapeutic peptides to treat autoimmune and allergic diseases, today announced the start of its second Phase I clinical trial of ATX-MS-1467, in patients with Multiple Sclerosis (MS)...............

http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2341

Posted: **Tue May 18, 2010 5:26 am**

By the Way Squiffs, I like it when you start new topics for each link. I can easily refind them and can read the ones I want. Also each one is a new topic, so I think each one should have a thread of discussion.

Posted: **Tue May 18, 2010 10:48 am**

I agree. Best to start a new thread for each item as the subject matter can be very different.

Cheers.....

This Is MS Multiple Sclerosis Knowledge & Support Community

Apitope starts new ATX-MS-1467 clinical trial

Apitope starts new ATX-MS-1467 clinical trial